Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application

  • Prev. Nav 13.72 11/28/09  
    Current Offer 13.67  
    YTD Return
    7.69% 10/31/09  
    52-Wk Low 9.67
    52-Wk High 13.86  
    Range 4.19  
    Total Assets
    300,000  
     
  • HCRDX is experiencing normal news volume

    Real-Time Headlines: HCRDX

    Customize
    • -

            • Set and Manage Alerts

              Alert me if
            • Related Information: HCRDX

              Fund Profile: HCRDX

              The investment seeks capital appreciation.

              The fund normally invests at least 80% of assets in common stocks (including depositary receipts) of health science companies throughout the world. It may invest up to 50% of net assets in foreign securities, including emerging-market securities. The fund may invest the remaining 20% of assets in the common stock of non-health science companies, preferred stock and investment-grade fixed-income securities.

              • Fund Manager:
                Michael Nolan , since 6/30/08
              • Fund Inception:
                7/28/97
              • Fund Ratings & Risk:
                View Ratings & Risk
              • Composition:
                STOCK (99.52%), BONDS (0.0%), CASH (0.48%), OTHER (0.0%)

              Top Fund Holdings: HCRDX

              Name % of Total Fund Assets
              Johnson (JNJ) 10.82 %
              Pfizer Inc (PFE) 10.07 %
              Wyeth (WYE) 5.06 %
              Abbott Laboratories (ABT) 4.75 %
              Bristol-Myers Squibb Company (BMY) 4.5 %
              View Holdings